WEBSITECHANGES

Website Changes

---

12/02/2017

Researchers identify vulnerability for glioblastoma subtypes

---

12/02/2017

Novel Agents for GBM: A Review of Trials at SNO 2017

---

12/01/2017

FDA Aims to Expand Early-Approval Program for Promising Drugs

---

11/24/2017

Effectiveness of ONC201 in H3 K27M Glioma to be Presented at SNO

---

11/24/2017

Ziopharm says its brain cancer drug helped trial patients live more than a year

---

11/24/2017

Inovio Starts Trial Testing Triple-combo Immunotherapy in Newly-diagnosed Glioblastoma

---

11/22/2017

Medicenna Presents Updates on Phase 2b Clinical Trial of MDNA55 at the Annual Meeting of the Society of Neuro-Oncology

---

11/21/2017

High compliance with Optune linked to greatest survival benefit for glioblastoma

---

11/21/2017

Lomustine and Bevacizumab in Progressive Glioblastoma.

---

11/21/2017

Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

---

11/21/2017

DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

---

11/17/2017

Patients Who Used Optune® More Than 90 Percent of the Time Had the Greatest Chance of Survival in Novocure’s EF-14 Trial: A Median Survival of 24.9 Months from Randomization and a Five-Year Survival of 29.3 Percent

---

11/17/2017

Toca 5 Trial is now open!

---

11/17/2017

GBM Heroes Honored By CURE

---

11/16/2017

National Cancer Institute designates UCLA brain cancer program a site of research excellence

---

11/15/2017

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

---

11/15/2017

Medicenna Presents Clinical Data From Previous Phase 1 and 2 Clinical Trials of MDNA55

---

11/10/2017

Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models

---

11/07/2017

Liquid Biopsy Spots Aggressive Pediatric Brainstem Cancer Earlier

---

11/05/2017

Making medicine, not money: How one U of T researcher`s startup is rethinking Big Pharma`s business model

---

11/05/2017

ONC201 Trial for Histone Mutant Glioma Begins at NYU

---

11/01/2017

U.S. experts set research agenda to meet `Cancer Moonshot` goals

---

10/30/2017

Health Beat: MDNA trial for glioblastoma

---

10/29/2017

Test Page

---

10/28/2017

Durable Responses Observed in Recurrent High Grade Glioma (rHGG) with Toca 511 & Toca FC Treatment

---